EyeGate Pharma - da brennt die Bude!
Seite 1 von 1 Neuester Beitrag: 03.01.22 10:44 | ||||
Eröffnet am: | 22.11.19 17:32 | von: moneywork4. | Anzahl Beiträge: | 14 |
Neuester Beitrag: | 03.01.22 10:44 | von: Fuks007 | Leser gesamt: | 5.545 |
Forum: | Hot-Stocks | Leser heute: | 2 | |
Bewertet mit: | ||||
Shares of EyeGate Pharmaceuticals Inc. EYEG, +47.39% rallied 95% in premarket trading on the news that the company's experimental eye-drop bandage performed better than the standard of care, which is a bandage contact lens, in patients in need of corneal wound repair. EyeGate plans to submit a de novo application to the Food and Drug Administration in the first six months of 2020. "If approved, [it] will be the first product indicated to repair corneal defects, as well as the first prescription hyaluronic acid eye drop in the U.S.," EyeGate CEO Stephen From said in a release. The company said it expects to receive additional data next week. EyeGate stock has fallen 31% year-to-date. The S&P 500 SPX, +0.01% has jumped 24%.
https://www.marketwatch.com/story/...-2019-11-22?mod=newsviewer_click
https://old.nasdaq.com/de/symbol/eyeg/real-time
About
http://www.eyegatepharma.com/
10,75 Mio. $ Offering
- 4,7 Mio. neue Aktien zu 2,30$
https://www.globenewswire.com/news-release/2021/...-Nasdaq-Rules.html